The combination of EPA+DHA and low-dose aspirin ingestion reduces platelet function acutely whereas each alone may not in healthy humans

INTRODUCTION: Aspirin’s effectiveness in reducing cardiovascular disease events is inadequate in some individuals, a phenomenon termed aspirin “resistance”. The hypothesis that combining low dose aspirin with eicosapentaenoic acid and docosahexaenoic acid (EPA+DHA) reduces platelet function in the a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Block, Robert C., Kakinami, Lisa, Jonovich, Matthew, Antonetti, Illena, Lawrence, Peter, Meednu, Nida, CalderonArtero, Pedro, Mousa, Shaker A., Brenna, J. Thomas, Georas, Steve
Formato: Artigo
Lenguaje:Inglês
Publicado: 2012
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3589139/
https://ncbi.nlm.nih.gov/pubmed/23017325
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.plefa.2012.08.007
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares